Skip to Main Content

Paper Details

Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate-Specific Membrane Antigen-Targeted <sup>18</sup>F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or Enzalutamide.
J Nucl Med
26
2021
Author NameAffiliation
Urban EmmeneggerSunnybrook Odette Cancer Centre and Research Institute, University of Toronto
Mark C MarkowskiSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine
Mario A EisenbergerSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine
Emmanuel S AntonarakisSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine
Kenneth J PientaJames Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine
  • 1 - 5

Datasets

Release 1.2